158 related articles for article (PubMed ID: 4619238)
21. [Experiments on the pathogenesis of Wilson's disease. 4. The action of alpha-lipoic acid on the metabolism of copper and proteins in cases of hepatolenticular degeneration (recent observations)].
da COSTA S; RODRIGUES EM; da SILVA J; RELVAS ME; HALPERN MJ
Gaz Med Port; 1960; 13():706-22. PubMed ID: 13695799
[No Abstract] [Full Text] [Related]
22. [Experimental reproduction of Wilson's disease].
Palladini G; Conforti A; Medolago L; Venturini G; Reitano M; Cerbo R; Pistone A
Acta Neurol (Napoli); 1974; 29(4):417-8. PubMed ID: 4451159
[No Abstract] [Full Text] [Related]
23. Tetrathiomolybdate causes formation of hepatic copper-molybdenum clusters in an animal model of Wilson's disease.
George GN; Pickering IJ; Harris HH; Gailer J; Klein D; Lichtmannegger J; Summer KH
J Am Chem Soc; 2003 Feb; 125(7):1704-5. PubMed ID: 12580588
[TBL] [Abstract][Full Text] [Related]
24. [Recent acquisitions in the study of Wilson's disease].
Sternlieb I
Rev Med Chir Mal Foie; 1965 Sep; 40(4):199-204. PubMed ID: 5851771
[No Abstract] [Full Text] [Related]
25. Wilson's disease: identification of an abnormal copper-binding protein.
Evans GW; Bubois RS; Hambidge KM
Science; 1973 Sep; 181(4105):1175-6. PubMed ID: 4726442
[TBL] [Abstract][Full Text] [Related]
26. [Kinetics of radioactive copper in Wilson's disease].
Willvonseder R; Goldstein NP; Tauxe WN
Wien Z Inn Med; 1973; 54(5):226-33. PubMed ID: 4790777
[No Abstract] [Full Text] [Related]
27. Wilson's disease patients with normal ceruloplasmin levels.
Yüce A; Koçak N; Ozen H; Gürakan F
Turk J Pediatr; 1999; 41(1):99-102. PubMed ID: 10770682
[TBL] [Abstract][Full Text] [Related]
28. Does orthotopic liver transplantation normalize copper metabolism in patients with Wilson's disease?
Diaz J; Acosta F; Cañizares F; Bueno FS; Tornel PL; Tovar I; Contreras RF; Marquez M; Martinez P; Parrilla P
Transplant Proc; 1995 Aug; 27(4):2306. PubMed ID: 7652819
[No Abstract] [Full Text] [Related]
29. Lysosomal defect of hepatic copper excretion in Wilson's disease (hepatolenticular degeneration).
Sternlieb I; Van den Hamer CJ; Morell AG; Alpert S; Gregoriadis G; Scheinberg IH
Gastroenterology; 1973 Jan; 64(1):99-105. PubMed ID: 4683859
[No Abstract] [Full Text] [Related]
30. Observations on copper metabolism in Wilson's disease.
Czlonkowska A; Galewicz A; Rodo M; Wehr H
Acta Univ Carol Med Monogr; 1973; 56():175-7. PubMed ID: 4791768
[No Abstract] [Full Text] [Related]
31. [Copper and nervous system. An experimental study (author's transl)].
Palladini G; Venturini G; Conforti A; Medolago-Albani L; Zelazek S; Pistone A; Scandurra R; Agnoli A
Pathol Biol (Paris); 1977 May; 25(5):299-306. PubMed ID: 195257
[TBL] [Abstract][Full Text] [Related]
32. Zinc therapy increases duodenal concentrations of metallothionein and iron in Wilson's disease patients.
Sturniolo GC; Mestriner C; Irato P; Albergoni V; Longo G; D'Incà R
Am J Gastroenterol; 1999 Feb; 94(2):334-8. PubMed ID: 10022625
[TBL] [Abstract][Full Text] [Related]
33. Diagnosis of Wilson's disease presenting as fulminant hepatic failure.
McCullough AJ; Fleming CR; Thistle JL; Baldus WP; Ludwig J; McCall JT; Dickson ER
Gastroenterology; 1983 Jan; 84(1):161-7. PubMed ID: 6847842
[TBL] [Abstract][Full Text] [Related]
34. Wilson's disease and copper metabolism--a review.
Manghani DK; Dastur DK
Indian J Gastroenterol; 1985 Apr; 4(2):91-3. PubMed ID: 3886537
[No Abstract] [Full Text] [Related]
35. [Aspects of chemical pathology in 2 cases of Wilson's disease].
Alloro L; Pecorari T
Riv Sper Freniatr Med Leg Alien Ment; 1968 Oct; 92(5):1381-401. PubMed ID: 5738558
[No Abstract] [Full Text] [Related]
36. Tracing copper-thiomolybdate complexes in a prospective treatment for Wilson's disease.
Zhang L; Lichtmannegger J; Summer KH; Webb S; Pickering IJ; George GN
Biochemistry; 2009 Feb; 48(5):891-7. PubMed ID: 19146437
[TBL] [Abstract][Full Text] [Related]
37. The role of metallothionein in the systemic distribution of cadmium.
Frazier JM
Dev Toxicol Environ Sci; 1982; 9():141-53. PubMed ID: 7053963
[No Abstract] [Full Text] [Related]
38. Copper balance and ceruloplasmin in chronic hepatitis in a Wilson disease animal model, LEC rats.
Komatsu Y; Ogra Y; Suzuki KT
Arch Toxicol; 2002 Sep; 76(9):502-8. PubMed ID: 12242607
[TBL] [Abstract][Full Text] [Related]
39. [The question of a false-structured ceruloplasmin in Wilson's disease].
Kühn HJ; Mörtzschky I
Z Med Lab Diagn; 1984; 25(5):250-6. PubMed ID: 6485485
[No Abstract] [Full Text] [Related]
40. Treatment of Wilson's disease with zinc. XIII: Therapy with zinc in presymptomatic patients from the time of diagnosis.
Brewer GJ; Dick RD; Yuzbasiyan-Gurkan V; Johnson V; Wang Y
J Lab Clin Med; 1994 Jun; 123(6):849-58. PubMed ID: 8201263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
